한국인에서 Dystrobrevin Binding Protein 1 (DTNBP1) 유전자의 다형성과 정신분열병의 연합에 대한 고찰

키워드

참고문헌 (33)

1. Tsuang MT, "Genes, environment and schizophrenia", Br J Psychiatry Suppl, 40, pp.s18~s24 (2001)
2. Karayiorgou M, "A turning point in schizophrenia genetics", Neuron, 19, pp.967~979 (1997)
3. "Synopsis of psychiatry 10th edition: Benjamin James Sadock", Virginia Alcott Sadock
4. Straub RE, "Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse bysbindin gene, is associated with schizophrenia", Am J Hum Genet, 71, pp.337~348 (2002)
5. Schwab SG, "Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families", Am J Hum Genet, 71, pp.185~190 (2003)
6. Van Den Bogaert A, "The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease", Am J Hum Genet, 73, pp.1438~1443 (2003)
7. Kirov G, "Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria", Biol Psychiatry, 55, pp.971~975 (2004)
8. Funke B, "Association of the DTNBP1 locus with schizophrenia in a U.S. population", Am J Hum Genet, 75, pp.891~898 (2004)
9. Tang JX, "Family-based association study of DTNBP1 in 6p22.3 and schizophrenia", Mol Psychiatry, 8, pp.717~718 (2003)
10. Numakawa T, "Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia", Hum Mol Genet, 13, pp.2699~2708 (2004)
11. Chi Un Pae, "Association between Dysbindin Gene(DTNBP1) and Schizophrenia in Korean Population", Korean J Schizophr Res, 9, pp.11~14 (2006)
12. 박동연, "정신분열병 가계에서 6p24-22 염색체에 대한 연관 분석", 신경정신의학, 45(5), pp.411~417 (2006), 대한신경정신의학회
13. Eun-Jeong Joo, "The dysbindin gene (DTNBP1) and schizophrenia: No support for an association in the Korean population", Neuroscience Letters, 407, pp.101~106 (2006)
14. Talbot K, "Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia", J Clin Invest, 113, pp.1353~1363 (2004)
15. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders, 4th ed revised" (1994), American Psychiatric Association
16. Faraone SV, "Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium", Am J Med Genet, 81, pp.290~295 (1998)
17. Gurling HM, "Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23", Am J Hum Genet, 68, pp.661~673 (2001)
18. Arinami T, "Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p", Am J Hum Genet, 77, pp.937~944 (2005)
19. Ekelund J, "Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22", Hum Mol Genet, 9, pp.1049~1057 (2000)
20. Fallin MD, "Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22", Am J Hum Genet, 73, pp.601~611 (2003)
21. Williams NM, "A systematic genomewide linkage study in 353 sib pairs with schizophrenia", Am J Hum Genet, 73, pp.1355~1367 (2003)
22. Mowry BJ, "Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample", Am J Med Genet, 96, pp.864~869 (2000)
23. Daniels JK, "Linkage study of chromosome 6p in sib-pairs with schizophrenia", Am J Med Genet, 74, pp.319~323 (1997)
24. Hugh MD Gurling, "Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1(DTNBP1) locus and schizophrenia", Behavioral and Brain Functions, 3, pp.50~ (2007)
25. Hai-Gwo Hwu, "No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese families", Schizophrenia Research, 93, pp.391~398 (2007)
26. Morris DW, "No evidence for association of the dysbindin gene(DTNBP1) with schizophrenia in an Irish population-based study", Schizophr Res, 60, pp.167~172 (2003)
27. Williams NM, "Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein 1 gene(DTNBP1)", Arch Gen Psychiatry, 61, pp.336~344 (2004)
28. Kim JS, "Low cerebrospinal glutamate in schizophrenic patients and a new hypothesis on schizophrenia", Neurosci Lett, 20, pp.379~382 (1980)
29. Goff DC, "Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia", Am J Psychiatry, 152, pp.1213~1215 (1995)
30. Goff DC, "A placebo controlled trial of d-cycloserine added to conventional neuroleptics in patients with schizophrenia", Arch Gen Psychiatry, 56, pp.21~27 (1999)
31. Heresco-Levy U, "Efficacy of high-dose glycerine in the treatment of enduring negative symptoms of schizophrenia", Arch Gen Psychiatry, 56, pp.29~36 (1999)
32. Javitt DC, "Ameloration of negative symptoms in schizophrenia by glycine", Am J Psychiatry, 151, pp.1234~1236 (1994)
33. Williams NM, "Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia", Mol Psychiatry, 8(5), pp.485~487 (2003)

관련 논문AI추천